Nicht aus der Schweiz? Besuchen Sie lehmanns.de
The Evolution of Drug Discovery - Enrique Ravina

The Evolution of Drug Discovery

From Traditional Medicines to Modern Drugs

(Autor)

Buch | Hardcover
XXXII, 496 Seiten
2011 | 1. Auflage
Wiley-VCH (Verlag)
978-3-527-32669-3 (ISBN)
CHF 109,95 inkl. MwSt
  • Versand in 10-14 Tagen
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken
Recounting the often spectacular successes and failures of innovative drugs, the reader is taken from the very beginnings of pharmacology to the multibillion dollar business that drugs are today. Highly knowledgeable, richly illustrated, inspiring, and fun to read.
Der Band zeichnet die oft spektakulären Erfolgs- oder Misserfolgsgeschichten neuartiger pharmazeutischer Wirkstoffe nach und nimmt den Leser dabei mit auf die Reise von den ersten Anfängen der Heilkunde bis zum Milliardengeschäft der modernen Pharmaindustrie. Sachkundig geschrieben, reich illustriert, anregend: Eine unterhaltsame Lektüre!

Enrique Ravina studied pharmacy at the University of Santiago de Compostela, Spain, where he obtained his PhD in 1969 and was appointed Professor of Organic Chemistry in 1975. Since 1981 he is Professor of Medicinal/Pharmaceutical Chemistry at the same University. He is a member of the Spanish Royal Academy of Pharmacy, a founding member of the Spanish Society of Medicinal Chemistry and a member of the American Chemical Society. Professor Ravina has over 120 publications to his name in the field of chemistry of drugs, especially in the area of antipsychotic and cardiovascular potential drugs, including a book, book chapters, as well as a co-inventor of the world patent "6-phenyldihydropyrrolopyrimidinedione derivatives".

Foreword
Preface and Acknowledgment

EVOLUTION OF DRUG DISCOVERY
Antiquity
Great Periods of Drug Discovery
Vaccines

THE FIRST SYNTHETIC DRUGS AND THE BIRTH OF CHEMOTHERAPY
Aspirin, Phenacetin, and Paracetamol
Discovery of Pyrazolones
Cocaine and Local Anesthetics
Barbiturates and Related Compounds
Fathers of Chemotherapy

FROM CASUAL OBSERVATIONS TO SYSTEMATIC SEARCH
From Antihistamines to Antipsychotics and Antidepressants: The Origins of Psychopharmacology
Benzodiazepines
Structural Variations on Sulfanilamide
Azoles as a Source of Antibacterials, Antifungals, and Antihelmintics
The Long Fight Against Cancer
Sildenafil - The First Inhibitor of Rectile Dysfunction

NATURE AS A SOURCE OF DRUGS: DRUGS FROM NATURAL PRODUCTS
Plant Sources: Derivatives and Related Drugs (Selected Examples)
Animal Sources: Derivatives and Related Drugs
Drugs from Microbiological Sources
Drugs from Marine Origin: The Contribution of the Sea to the Therapeutic Arsenal

RATIONALIZING THE DRUG DISCOVERY PROCESS
Early Rational Drug Discovery Approaches: L-Dopa and L-Alpha-Methyldopa
Receptor-Based Drug Discovery
Antimetabolites in the Fight Against Bacteria, Viruses, and Cancer
Cyclooxygenase(COX) Inhibitors

STRUCTURE-BASED DRUG DISCOVERY
Searching for the Ideal Antihypertensive Agent: Renin-Angiotensin-Aldosterone System (RAAS)
HIV Protease Inhibitors
Drugs Effective Against the Influenza Virus (the Flu)
Fight Against Cancer
New Avenues for the Development of Antidiabetic Agents. Dipeptidyl-Peptidase-IV Inhibitors: Sitagliptin and Vildaglptin

BIOPHARMACEUTICALS
Monoclonal Antibodies (MAbs)
Recombinant DNA Technology (Genetic Engineering)
Some Recombinant Protein Drugs
Protein-Polyethyleneglycol (PEG) Conjugates (Protein PEGylation)

DRUG DISCOVERY IN THE POSTGENOMIC ERA: CONCLUDING REMARKS
Chemical/Genomic Strategy
Summary

"This serves as an excellent companion to many of the popular medicinal chemistry and pharmacology books, and gives students additional insight into the contemporary drug discovery process." (Doody s, 16 March 2012)

"The text is well referenced and complete with chemical illustrations. . . Recommended. Upper-division undergraduates through professionals." (Choice, 1 October 2011)
"It can be used by students interested in the classic achievements and case stories of drug discovery, but also by more experienced scientists as a guiding overview on the field. Last but not least, it serves well as a compendium to industrial professionals in the field of biomedical and medicinal chemistry research." (ChemMedChem, 2011)

Erscheint lt. Verlag 18.3.2011
Vorwort Hugo Kubinyi
Sprache englisch
Maße 170 x 240 mm
Gewicht 1145 g
Themenwelt Sachbuch/Ratgeber Natur / Technik Naturwissenschaft
Medizin / Pharmazie Pharmazie
Schlagworte Arzneimittel • Arzneimittelentwicklung • Arzneimittelforschung • Chemie • Chemistry • Drug Discovery & Development • Drug Discovery & Development • Medical Science • Medizin • Organic Chemistry • Organische Chemie • Pharmacology & Pharmaceutical Medicine • Pharmacology & Pharmaceutical Medicine • Pharmakologie u. Pharmazeutische Medizin • Wirkstoffforschung • Wirkstoffforschung u. -entwicklung
ISBN-10 3-527-32669-3 / 3527326693
ISBN-13 978-3-527-32669-3 / 9783527326693
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
Kaleidoskop der Mathematik

von Ehrhard Behrends; Peter Gritzmann; Günter M. Ziegler

Buch | Hardcover (2024)
Springer (Verlag)
CHF 46,15
Die glänzenden und die dunklen Jahre der Physik 1895-1945

von Tobias Hürter

Buch | Softcover (2023)
Klett-Cotta (Verlag)
CHF 19,55
wie sie denkt, fühlt und Probleme löst

von Lars Chittka

Buch | Hardcover (2024)
Folio (Verlag)
CHF 39,90